Home › Acute Myeloid Leukemia › California › Baldwin Park
Acute Myeloid Leukemia clinical trials in Baldwin Park, CA
40 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Baldwin Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
RecruitingPhase 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · 4 mi away
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
RecruitingPhase 3
- Clinical Trial Site, Duarte · 4 mi away
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RecruitingPhase 3
- City of Hope, Duarte · 4 mi away
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
RecruitingPhase 1
- City of Hope National Medical Center, Duarte · 4 mi away
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RecruitingPhase 1/2Healthy volunteers welcome
- City of Hope, Duarte · 4 mi away
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
RecruitingPhase 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RecruitingPhase 1/2
- City of Hope National Medical Center, Duarte · 4 mi away
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Individualized AML Treatment
RecruitingObservational study
- City of Hope Medical Center, Duarte · 4 mi away
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
RecruitingPhase 2
- City of Hope Medical Center, Duarte · 4 mi away
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecruitingPhase 1Healthy volunteers welcome
- City of Hope Medical Center, Duarte · 4 mi away
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
RecruitingPhase 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4 mi away
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- City of Hope, Duarte · 4 mi away
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
RecruitingPhase 2
- City of Hope Medical Center, Duarte · 4 mi away
A Study of Revumenib and Mezigdomide in People With Leukemia
RecruitingPhase 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi away
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
RecruitingPhase 1Healthy volunteers welcome
- City of Hope Medical Center, Duarte · 4 mi away
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- City of Hope, Duarte · 4 mi away
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
RecruitingPhase 2Healthy volunteers welcome
- City of Hope Medical Center, Duarte · 4 mi away
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
RecruitingPhase 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi away
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
RecruitingPhase 2
- City of Hope Medical Center, Duarte · 4 mi away
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- City of Hope - Duarte, Duarte · 4 mi away
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
RecruitingPhase 1
- City of Hope Medical Center, Duarte · 4 mi away
Study of REM-422 in Patients With AML or Higher Risk MDS
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
RecruitingPhase 1
- City of Hope National Medical Center, Duarte · 4 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Seattle, WA41 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA31 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
- Washington, DC24 studies
Other studies in Baldwin Park
- Breast Cancer44 studies
- Colorectal Cancer37 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)34 studies
- Prostate Cancer30 studies
- Metastatic Cancer30 studies
- Myelodysplastic Syndromes26 studies
- Ovarian Cancer25 studies
- Lung Cancer24 studies
- Multiple Myeloma23 studies
- Stomach Cancer22 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.